# Nuclide record decision-sorafenib (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/decision-sorafenib/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "decision-sorafenib", "NCT00984282" ;
  schema:name "DECISION"@en ;
  schema:description "The first drug approved for thyroid cancers that stopped responding to radioactive iodine."@en ;
  schema:url <https://nuclide.cc/trials/decision-sorafenib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00984282>, <https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60421-9/fulltext> ;
  nuclide:status "positive" ;
  nuclide:phase "3" ;
  nuclide:indications <https://nuclide.cc/indications/thyroid/> .